InsidersTradesSigma
Explore the full record of transactions filed by MacLean Michael F, Chief Financial Officer. Officer active across 1 companies, notably Avidity Biosciences, Inc.. Aggregated, 2 reports have been recorded. Total volume traded: €2.3m. The latest transaction was filed on 6 August 2025 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Michael F. MacLean is the Chief Financial Officer of Avidity Biosciences, Inc. In this role, he oversees the financial operations of the company, including financial planning, risk management, and financial reporting. His expertise contributes to the financial health and growth of the company.